Skip to content
Discover expert analysis on UK property markets, investment…

Zimbabwe Rejects ‘Unbalanced’ US Healthcare Assistance Package Due to Information Concerns

Medical funding image
The offered US financial assistance was aimed at initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

The nation of Zimbabwe has rejected a significant US healthcare agreement worth 367 million US dollars (£272m) over five years because of Washington's insistence on sensitive biological samples.

This rejection was revealed following a internal memorandum dated December was leaked, revealing that President Emmerson Mnangagwa deemed the agreement was "skewed".

A government representative has since stated that the United States was requesting biological samples for scientific study and commercial purposes while was unwilling to guarantee the resulting advantages from any future medical innovations.

"We must now begin the difficult and regrettable task of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has called for further negotiations to secure a agreement agreeable to all parties so the country's vital HIV treatment initiative can be sustained.

Wider Implications

This rejection comes after a comparable case in neighbouring Kenya, where a high court suspended a similar health funding agreement following concerns were raised about the security of citizens' health data.

Since resuming the presidency recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).

The agency had administered aid for the American government, but Trump argued its spending was "inefficient" and his government was seeking government-to-government deals to boost transparency and responsibility.

Based on reports, 16 nations in Africa have to date agreed to similar agreements, constituting over $18.3bn in new funding.

Details of the Declined Agreement

The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this cooperation could have provided immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving HIV treatment through US-supported initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".

"Our nation was requested to share its genetic material and health information indefinitely, without any corresponding guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.

"Put simply, our nation would provide the raw materials for scientific discovery with no certainty that the resulting innovations would be accessible to our population if a new health crisis emerge."

Sovereignty and Global Health

He also pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were undermining systems previously set up through the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to manage potential global health emergencies.

"This mechanism is intended to guarantee that when a country provides its information, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the funds to create them."

These objections regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We are open to continued dialogue with our US partners on how subsequent co-operation could be designed in a manner that respects the independence and interests of each country."

Health Experts Response

A leading public health body stated it acknowledged the official position, but suggested that talks must proceed considering a large portion of the nation's HIV programmes depended on international support.

"Where technical issues exist, such as those relating to data governance or agreement terms, these can often be resolved via technical clarification and mutually agreed protections," it added.

This impasse highlights the continuing debate between accepting much-needed international aid and protecting local interests in an ever more data-driven world.

JS
About the author

Julie Simpson

Property analyst with over 15 years of experience in real estate markets and investment planning.

Market Project UK

Type to search articles.